Apolipoprotein E alleles as risk factors in Alzheimer's disease.
about
Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's diseaseApoE promotes the proteolytic degradation of AbetaThe Rationale for Insulin Therapy in Alzheimer's DiseaseGenes associated with Alzheimer's disease: an overview and current statusAlzheimer's Disease: Mechanism and Approach to Cell TherapyRole of apolipoprotein E in neurodegenerative diseasesNetwork dysfunction in Alzheimer's disease: refining the disconnection hypothesisThe role of APOE-ɛ4 and beta amyloid in the differential rate of recovery from ECT: a reviewGenetic of Alzheimer's Disease: A Narrative Review ArticleOcular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?Buying time: a rationale for examining the use of circadian rhythm and sleep interventions to delay progression of mild cognitive impairment to Alzheimer's diseaseApolipoprotein E: isoform specific differences in tertiary structure and interaction with amyloid-β in human Alzheimer brainInteraction of the apolipoprotein E receptors low density lipoprotein receptor-related protein and sorLA/LR11Exercise, APOE genotype, and the evolution of the human lifespanRelated genes and potential biomarkers for early diagnosis of Alzheimer's disease: a preliminary study based on DNA microarray.Apolipoprotein E4 domain interaction: synaptic and cognitive deficits in miceApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice.Stem cell derived basal forebrain cholinergic neurons from Alzheimer's disease patients are more susceptible to cell death.ω-3 fatty acids and domain-specific cognitive aging: secondary analyses of data from WHISCA.Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice.Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers.Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients.White matter microstructure in late middle-age: Effects of apolipoprotein E4 and parental family history of Alzheimer's diseaseAssociation of apolipoprotein E-219T>G promoter polymorphism with primary open angle glaucoma in Turkish population.Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E.Dementia and cognitive impairment: epidemiology, diagnosis, and treatment.APOE polymorphisms and cognitive functions in patients with brain tumorsImpact of gene patents and licensing practices on access to genetic testing for Alzheimer disease.Anti-inflammatory drugs: a hope for Alzheimer's disease?Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scansLow density lipoprotein receptor-related protein 1 dependent endosomal trapping and recycling of apolipoprotein E.Pathological aspects of lipid peroxidation.Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism.Cultural aspects of dementia.Mining for SNPs: putting the common variants--common disease hypothesis to the test.Preventing vascular effects on brain injury and cognition late in life: knowns and unknowns.Linking cardiometabolic disorders to sporadic Alzheimer's disease: a perspective on potential mechanisms and mediators.Gene identification in Alzheimer's disease.Defining the genetic contribution of type 2 diabetes mellitus.Alzheimer diseases: a model of gene mutations and susceptibility polymorphisms for complex psychiatric diseases.
P2860
Q22248091-5AF2D311-37F2-46B5-8676-52F44184D5B0Q24651102-70DFCCF4-968E-4A74-9E4F-9B68CC24C0AEQ26744834-573926B0-C891-4680-B04F-4BF0431A9457Q26747803-1AB66831-8EA5-40D9-9B90-5DD1750074AFQ26778149-B1ADCA0D-40B7-46DA-999F-165FAD83362AQ26799413-9629D051-3934-4372-B690-C5E5F03DD91AQ26995432-43BF3DD5-C889-4D14-A086-27A27347B588Q27001073-80DD9D32-0F20-445F-A97C-AF7535D11FD2Q27007467-A89D8FB3-CE79-4D9C-A006-46BA7B02A850Q27021069-3F04AA77-3B5E-430F-B3CC-510B1CF7299AQ28383805-A75CD7ED-3223-4FF0-8B2A-295A0534BB01Q28477020-D2A29526-98A9-4213-AA78-3B42F87225CDQ28509728-2229FE14-FEC6-402A-A1A3-EC06B38A10AAQ28657798-C7CFA494-3F87-4F7D-86AF-F8FED120B13DQ30357425-CC5365D8-4566-4770-8C4B-5749978D4CE4Q30486146-399C36A3-36C9-4581-AB44-C02D6E25B52AQ30539979-1BCD89B2-342F-4F3B-B83F-998BBE3AB485Q30566020-7F9119AB-87FC-4A3F-B431-97BCD027237BQ30670248-EE217E5A-60DE-4D9E-BEF1-FE34CC167C64Q31122715-A1193553-DDBE-4909-9DD7-C330F2256F7FQ33456273-9B45CECC-96B7-452C-B9DE-B5025DB8DCE0Q33607473-54CA09BC-3969-4215-A798-A762B23A163BQ33741447-8CB64A89-3DF1-4FCD-8318-98F3E2760B9DQ33794957-C653D68B-7E4D-46F4-8D2B-8317BA8070C3Q33919169-49357703-A3B2-4762-908A-7B9B2C52355FQ33924014-D5706864-E2D7-424A-BDC5-B2B4BE6C218BQ33972402-AB6B2C98-BFA7-47E3-9513-391542826894Q34032455-80939DCC-0715-4FF9-AEE9-35642E5F9AB2Q34074779-765B5D4C-1DCB-4EB6-8417-74DA07C7DC79Q34081087-0544816E-5DBA-4E20-AF05-30035F52EDBFQ34125060-8F81B289-EDA4-491D-84DE-0ACAFBAAB21BQ34137628-90B977FB-4D57-4E70-B259-1A1FD65FB3B0Q34144158-08470EA2-8C16-4129-9F56-B6E04725D349Q34174238-1AC9F6D6-D006-4BD2-8A3C-A96ECB33014CQ34189877-E04546CE-4EEF-4020-A25E-4751BB3651D2Q34212947-B47F5504-C001-4C80-B59D-28414542B0F0Q34268223-762650DF-B1A4-4B8D-8DE9-6C2401C3A14BQ34355252-83531D73-2A3E-4AA6-A376-9FF68B59CA41Q34362130-48E2BC1B-F4F7-46AA-AED0-9B3EAE278ACEQ34461295-E66F765B-6E8D-4E14-B1FC-E532CBB057BA
P2860
Apolipoprotein E alleles as risk factors in Alzheimer's disease.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Apolipoprotein E alleles as risk factors in Alzheimer's disease.
@en
type
label
Apolipoprotein E alleles as risk factors in Alzheimer's disease.
@en
prefLabel
Apolipoprotein E alleles as risk factors in Alzheimer's disease.
@en
P1476
Apolipoprotein E alleles as risk factors in Alzheimer's disease.
@en
P2093
P304
P356
10.1146/ANNUREV.MED.47.1.387
P577
1996-01-01T00:00:00Z